TPST2 Gene - Tyrosylprotein Sulfotransferase 2
Genetic and Functional Insights into TPST2, a Key Enzyme in Protein Tyrosine O-Sulfation
Gene Information Card
| Symbol | TPST2 |
|---|---|
| Full Name | tyrosylprotein sulfotransferase 2 |
| Gene Type | protein coding |
| Chromosomal Location | 22q12.1 |
| NCBI Gene ID | 8459 ncbi.nlm.nih.gov/gene/8459 |
| Ensembl ID | ENSG00000100116 |
| UniProt ID | O60704 |
| OMIM ID | 603126 |
| HGNC ID | 12021 |
| Aliases | TPST-2 |
Description
The TPST2 gene encodes tyrosylprotein sulfotransferase 2, an enzyme localized to the trans-Golgi network that catalyzes the transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to tyrosine residues on proteins. This post-translational modification, known as tyrosine O-sulfation, is critical for protein-protein interactions, receptor-ligand binding, and immune cell trafficking. TPST2 is widely expressed and plays roles in development, hemostasis, and inflammatory responses. Mutations in TPST2 have been linked to congenital hypothyroidism and other developmental disorders.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Congenital hypothyroidism | Loss-of-function mutations in TPST2 impair sulfation of thyroglobulin and other thyroid proteins, disrupting thyroid hormone synthesis. | ClinVar; OMIM (603126) |
| Thyroid dyshormonogenesis | Biallelic mutations in TPST2 cause autosomal recessive thyroid dyshormonogenesis, leading to goiter and hypothyroidism. | OMIM; PubMed (e.g., PMID 29281825) |
| Developmental delay (potential) | Altered sulfation of neuronal proteins may affect brain development, though direct evidence is limited. | UniProt; literature review |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Thyroid | 12.5 | Medium |
| Liver | 10.2 | Medium |
| Kidney | 8.7 | Medium |
| Brain | 6.3 | Low |
| Testis | 5.1 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HeLa | 15.3 | Cervical carcinoma; high expression |
| HepG2 | 12.8 | Hepatocellular carcinoma; moderate-high |
| A549 | 9.4 | Lung carcinoma; moderate |
| MCF7 | 7.2 | Breast adenocarcinoma; moderate-low |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.253C>T (p.Arg85*) | Nonsense | Rare (allele frequency <0.01%) | Premature stop codon; loss of function |
| c.1043G>A (p.Arg348His) | Missense | Rare (allele frequency <0.01%) | Impaired catalytic activity; reduced sulfation |
| c.1246C>T (p.Arg416Trp) | Missense | Rare (allele frequency <0.01%) | Structural disruption; loss of function |
Mutation functional classification
Loss of Function (LOF)
Nonsense and missense mutations that reduce or abolish enzyme activity, leading to impaired tyrosine sulfation and associated phenotypes such as congenital hypothyroidism.
Gain of Function (GOF)
No evidence for gain-of-function mutations in TPST2; all reported pathogenic variants are loss-of-function.
Dominant Negative (DN)
No evidence for dominant-negative effects; TPST2 mutations are typically recessive.
View complete mutation data:
Gene Ontology (GO)
| • sulfotransferase activity | • protein tyrosine sulfation |
| • Golgi apparatus | • trans-Golgi network |
| • 3'-phosphoadenosine 5'-phosphosulfate binding | • integral component of membrane |
Pathways
• Protein modification; protein sulfation
• Metabolism of cofactors and vitamins (PAPS metabolism)
• Post-translational protein modification
Protein Summary
TPST2 is a type II transmembrane protein of the Golgi apparatus, consisting of a short cytoplasmic tail, a transmembrane domain, and a large luminal catalytic domain. It transfers sulfate from PAPS to tyrosine residues in target proteins, a modification essential for protein-protein interactions. The enzyme is involved in the sulfation of chemokine receptors, adhesion molecules, and hormones, influencing immune responses and endocrine function. Structural studies reveal a conserved sulfotransferase domain with a PAPS-binding motif. TPST2 functions as a homodimer and is ubiquitously expressed, with highest levels in thyroid and liver. Its activity is regulated by substrate availability and cellular localization.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TPST2 Knockout HEK293 Cell Line | EDJ-KQ5546 | Human | 8459 | Details Get a Quote |
| TPST2 Knockout A-549 Cell Line | EDJ-KQ30109 | Human | 8459 | Details Get a Quote |
| TPST2 Knockout HCT 116 Cell Line | EDJ-KQ30111 | Human | 8459 | Details Get a Quote |
| TPST2 Knockout HeLa Cell Line | EDJ-KQ30112 | Human | 8459 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records